Skip to main content
  • More from ADA
    • Diabetes Care
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care in Diabetes
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care
  • Subscribe
  • Log in
  • My Cart
  • Follow ada on Twitter
  • RSS
  • Visit ada on Facebook
Diabetes

Advanced Search

Main menu

  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • ADA Scientific Sessions Abstracts
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • ADA Scientific Sessions Abstracts
    • Diabetes COVID-19 Article Collection
    • Diabetes Symposium 2020
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Submit Cover Art
    • ADA Journal Policies
    • Instructions for Authors
    • ADA Peer Review
  • More from ADA
    • Diabetes Care
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care in Diabetes
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care

User menu

  • Subscribe
  • Log in
  • My Cart

Search

  • Advanced search
Diabetes
  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • ADA Scientific Sessions Abstracts
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • ADA Scientific Sessions Abstracts
    • Diabetes COVID-19 Article Collection
    • Diabetes Symposium 2020
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Submit Cover Art
    • ADA Journal Policies
    • Instructions for Authors
    • ADA Peer Review
Original Article

Inactivation of GSK-3β by Metallothionein Prevents Diabetes-Related Changes in Cardiac Energy Metabolism, Inflammation, Nitrosative Damage, and Remodeling

  1. Yuehui Wang1,2,
  2. Wenke Feng1,2,
  3. Wanli Xue2,
  4. Yi Tan1,2,3,
  5. David W. Hein4,
  6. Xiao-Kun Li1,5 and
  7. Lu Cai1,2,3,4
  1. 1Chinese-American Research Institute for Diabetic Complications, Wenzhou Medical College, Zhejiang, China;
  2. 2Department of Medicine, University of Louisville, Louisville, Kentucky;
  3. 3Department of Pediatrics, University of Louisville, Louisville, Kentucky;
  4. 4Department of Pharmacology and Toxicology, University of Louisville, Louisville, Kentucky;
  5. 5Engineering Research Center of Bioreactor and Pharmaceutical Development, Jilin Agricultural University, Jilin, China.
  1. Corresponding authors: Lu Cai, l0cai001{at}louisville.edu, and Xiao-Kun Li, xiaokunli{at}163.net.
Diabetes 2009 Jun; 58(6): 1391-1402. https://doi.org/10.2337/db08-1697
PreviousNext
  • Article
  • Figures & Tables
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 58 no. 6 1391-1402
DOI 
https://doi.org/10.2337/db08-1697
PubMed 
19324938

Published By 
American Diabetes Association
Print ISSN 
0012-1797
Online ISSN 
1939-327X
History 
  • December 7, 2008
  • March 10, 2009
  • Published in print May 21, 2009.
  • Published online ahead of print March 26, 2009.

Article Versions

  • Previous version (March 26, 2009 - 06:54).
  • You are viewing the most recent version of this article.
Copyright & Usage 
© 2009 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details.

Author Information

  1. Yuehui Wang1,2,
  2. Wenke Feng1,2,
  3. Wanli Xue2,
  4. Yi Tan1,2,3,
  5. David W. Hein4,
  6. Xiao-Kun Li1,5 and
  7. Lu Cai1,2,3,4
  1. 1Chinese-American Research Institute for Diabetic Complications, Wenzhou Medical College, Zhejiang, China;
  2. 2Department of Medicine, University of Louisville, Louisville, Kentucky;
  3. 3Department of Pediatrics, University of Louisville, Louisville, Kentucky;
  4. 4Department of Pharmacology and Toxicology, University of Louisville, Louisville, Kentucky;
  5. 5Engineering Research Center of Bioreactor and Pharmaceutical Development, Jilin Agricultural University, Jilin, China.
  1. Corresponding authors: Lu Cai, l0cai001{at}louisville.edu, and Xiao-Kun Li, xiaokunli{at}163.net.
View Full Text

Statistics from Altmetric.com

Article usage

Article usage: March 2009 to April 2021

Rendering graph...
AbstractFullPdf
Mar 200955049
Apr 200965090
May 200963027
Jun 20097742140
Jul 20092921426
Aug 200912586
Sep 200912621317
Oct 200912416315
Nov 200984826
Dec 200998887
Jan 2010839124
Feb 2010616019
Mar 2010808312
Apr 2010726315
May 201054654
Jun 2010455623
Jul 2010474728
Aug 2010634716
Sep 2010314020
Oct 2010424421
Nov 2010263629
Dec 2010163216
Jan 2011332426
Feb 2011303223
Mar 2011272828
Apr 2011376441
May 2011234529
Jun 2011184123
Jul 2011253231
Aug 2011432733
Sep 2011562929
Oct 2011373129
Nov 2011582431
Dec 2011482335
Jan 2012333742
Feb 2012342228
Mar 2012391622
Apr 2012503926
May 2012423225
Jun 2012451831
Jul 2012301516
Aug 2012331815
Sep 2012302118
Oct 2012212422
Nov 2012321415
Dec 2012271617
Jan 201335149
Feb 2013432812
Mar 2013381211
Apr 2013311312
May 2013401427
Jun 201329107
Jul 2013351211
Aug 201327148
Sep 2013221212
Oct 201353129
Nov 2013221811
Dec 20131755
Jan 2014282410
Feb 20149269
Mar 2014332112
Apr 2014202218
May 2014291511
Jun 2014573236
Jul 2014312910
Aug 2014151411
Sep 2014251011
Oct 201424811
Nov 201428714
Dec 2014177316
Jan 201525129
Feb 20151354
Mar 201529207
Apr 201525127
May 201511214
Jun 2015192924
Jul 2015222219
Aug 201510179
Sep 201516158
Oct 201514292
Nov 20159177
Dec 2015271811
Jan 201628317
Feb 2016341922
Mar 20165621146
Apr 2016172224
May 2016114824
Jun 2016122618
Jul 2016153533
Aug 201673421
Sep 201623399
Oct 2016156227
Nov 2016337122
Dec 201665111
Jan 20178359
Feb 20176419
Mar 20174425
Apr 20172407
May 20173303
Jun 201732510
Jul 201732411
Aug 20175208
Sep 201772010
Oct 201726115
Nov 201772407
Dec 20175844
Jan 2018103810
Feb 20186249
Mar 201854112
Apr 201814511
May 20180371
Jun 20182362
Jul 20186278
Aug 20181113
Sep 20181458
Oct 20182914
Nov 201821158
Dec 2018110223
Jan 201957820
Feb 201959514
Mar 2019417027
Apr 2019116817
May 2019512418
Jun 201939914
Jul 2019321232
Aug 2019549214
Sep 2019457918
Oct 2019432011
Nov 2019321717
Dec 201951187
Jan 20202914
Feb 202011113
Mar 202001111
Apr 2020467
May 202032910
Jun 202032011
Jul 202012614
Aug 20205802
Sep 20200249
Oct 202013914
Nov 202042816
Dec 202042511
Jan 202142124
Feb 20211316
Mar 20212175
Apr 2021265

PreviousNext
Back to top

In this Issue

June 2009, 58(6)
  • Table of Contents
  • Index by Author
Sign up to receive current issue alerts
View Selected Citations (0)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about Diabetes.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Inactivation of GSK-3β by Metallothionein Prevents Diabetes-Related Changes in Cardiac Energy Metabolism, Inflammation, Nitrosative Damage, and Remodeling
(Your Name) has forwarded a page to you from Diabetes
(Your Name) thought you would like to see this page from the Diabetes web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Inactivation of GSK-3β by Metallothionein Prevents Diabetes-Related Changes in Cardiac Energy Metabolism, Inflammation, Nitrosative Damage, and Remodeling
Yuehui Wang, Wenke Feng, Wanli Xue, Yi Tan, David W. Hein, Xiao-Kun Li, Lu Cai
Diabetes Jun 2009, 58 (6) 1391-1402; DOI: 10.2337/db08-1697

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Add to Selected Citations
Share

Inactivation of GSK-3β by Metallothionein Prevents Diabetes-Related Changes in Cardiac Energy Metabolism, Inflammation, Nitrosative Damage, and Remodeling
Yuehui Wang, Wenke Feng, Wanli Xue, Yi Tan, David W. Hein, Xiao-Kun Li, Lu Cai
Diabetes Jun 2009, 58 (6) 1391-1402; DOI: 10.2337/db08-1697
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • RESEARCH DESIGN AND METHODS
    • RESULTS
    • DISCUSSION
    • Acknowledgments
    • Footnotes
    • REFERENCES
  • Figures & Tables
  • Info & Metrics
  • PDF

Related Articles

Cited By...

More in this TOC Section

Original Article

  • An Update on the Molecular Actions of Fenofibrate and Its Clinical Effects on Diabetic Retinopathy and Other Microvascular End Points in Patients With Diabetes
  • Loss of Prohibitin Induces Mitochondrial Damages Altering β-Cell Function and Survival and Is Responsible for Gradual Diabetes Development
  • Cbl-b Is a Critical Regulator of Macrophage Activation Associated With Obesity-Induced Insulin Resistance in Mice
Show more Original Article

Complications

  • Novel Linkage Peaks Discovered for Diabetic Nephropathy in Individuals With Type 1 Diabetes
  • Lung and Kidney ACE2 and TMPRSS2 in Renin-Angiotensin System Blocker–Treated Comorbid Diabetic Mice Mimicking Host Factors That Have Been Linked to Severe COVID-19
  • Specific NLRP3 Inhibition Protects Against Diabetes-Associated Atherosclerosis
Show more Complications

Similar Articles

Navigate

  • Current Issue
  • Online Ahead of Print
  • Scientific Sessions Abstracts
  • Collections
  • Archives
  • Submit
  • Subscribe
  • Email Alerts
  • RSS Feeds

More Information

  • About the Journal
  • Instructions for Authors
  • Journal Policies
  • Reprints and Permissions
  • Advertising
  • Privacy Policy: ADA Journals
  • Copyright Notice/Public Access Policy
  • Contact Us

Other ADA Resources

  • Diabetes Care
  • Clinical Diabetes
  • Diabetes Spectrum
  • Scientific Sessions Abstracts
  • Standards of Medical Care in Diabetes
  • BMJ Open - Diabetes Research & Care
  • Professional Books
  • Diabetes Forecast

 

  • DiabetesJournals.org
  • Diabetes Core Update
  • ADA's DiabetesPro
  • ADA Member Directory
  • Diabetes.org

© 2021 by the American Diabetes Association. Diabetes Print ISSN: 0012-1797, Online ISSN: 1939-327X.